Learn More About our Award

Learn More About ReNeuron

Latest News

View all

Directorate Change – Catherine Isted appointed as Chief Executive Officer

Preliminary Results for the year ended 31 March 2022

Update on the Technology Transfer and Supply Agreement with Fosun Pharma

Notice of Results – Analyst meeting and Investor presentation

ReNeuron to present at International Society of Cell and Gene Therapy

Exosomes

 Exosomes banner image Read more

iPSC

 CTX cells for Critical Limb Ischaemia Read more

Investor Centre

 Investor Centre banner image Read more

The information collected will be used to send you the information you have requested and to provide information that may be useful to you. ReNeuron may share non-personal aggregate statistics (group) data about ReNeuron’s website visitors with partners or other parties. However, ReNeuron will not sell or share any information about individual users. Please ensure you have read the full contents of our Privacy Notice before continuing. If you agree to your information being used in this way, please tick the box: